drugset / Trial / NCT05348239

Chlorophyllin Tablets for Urinary Bleeding Following Radiation Therapy for Cancers of Pelvic Organs

NCT05348239 ↗

NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy of oral chlorophyllin tablets for urinary bleeding following radiation therapy for cancers of pelvic organs.

Timeline

Start
2022-03-26
Primary completion
2024-03-31
Completion
2024-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CHLOROPHYLLIN COPPER COMPLEX Unknown 750 mg Oral

Indications